Literature DB >> 3103944

Moyamoya disease--a review of clinical experience and anaesthetic management.

S C Brown, A M Lam.   

Abstract

Moyamoya disease is a rare neurovascular condition that affects both children and adults. Increasingly these patients present for surgical management to improve the cerebral circulation since medical therapy is essentially ineffective. Because of the precarious cerebral circulation, these patients represent an anaesthetic challenge. In this report we review the pathophysiology of moyamoya disease, summarize our experience with seven patients and discuss the anaesthetic management.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103944     DOI: 10.1007/BF03007690

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  20 in total

1.  The effects of isoflurane on canine cerebral metabolism and blood flow.

Authors:  R F Cucchiara; R A Theye; J D Michenfelder
Journal:  Anesthesiology       Date:  1974-06       Impact factor: 7.892

2.  Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method.

Authors:  S Takeuchi; R Tanaka; R Ishii; T Tsuchida; K Kobayashi; H Arai
Journal:  Surg Neurol       Date:  1985-05

3.  Moyamoya disease and anesthesia.

Authors:  K Sumikawa; H Nagai
Journal:  Anesthesiology       Date:  1983-02       Impact factor: 7.892

4.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

5.  Moyamoya disease associated with intracranial aneurysms.

Authors:  M Yabumoto; K Funahashi; T Fujii; S Hayashi; N Komai
Journal:  Surg Neurol       Date:  1983-07

6.  Anaesthetic management in Moya-moya disease.

Authors:  R M Bingham; D J Wilkinson
Journal:  Anaesthesia       Date:  1985-12       Impact factor: 6.955

7.  Cerebrovascular occlusive disease with and without the moyamoya vascular network in children.

Authors:  T Kurokawa; Y J Chen; S Tomita; T Kishikawa; K Kitamura
Journal:  Neuropediatrics       Date:  1985-02       Impact factor: 1.947

8.  Treatment of acute deficits of moyamoya disease with verapamil.

Authors:  M J McLean; S S Gebarski; A F van der Spek; G W Goldstein
Journal:  Ann Acad Med Singapore       Date:  1985-01       Impact factor: 2.473

9.  Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis ("moyamoya" disease) in children.

Authors:  Y Fukuyama; R Umezu
Journal:  Brain Dev       Date:  1985       Impact factor: 1.961

Review 10.  Stroke syndromes in childhood.

Authors:  G S Golden
Journal:  Neurol Clin       Date:  1985-02       Impact factor: 3.806

View more
  6 in total

1.  Hypocarbia during anaesthesia in children with moyamoya disease.

Authors:  J D Martino; L O Werner
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

2.  Moyamoya disease, revascularisation surgery and anaesthetic considerations.

Authors:  Yashar Ilkhchoui; Pramod V Panikkath; Hugh Martin
Journal:  BMJ Case Rep       Date:  2014-01-08

3.  Intraoperative monitoring in patients with moyamoya disease.

Authors:  D H Wong; D H McLeod
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

4.  Anaesthetic management of a patient with Moyamoya disease for Caesarean section.

Authors:  B Venkatesh; P C Taggart
Journal:  Can J Anaesth       Date:  1994-01       Impact factor: 5.063

5.  Preoperative assessment of adult patients for intracranial surgery.

Authors:  Vanitha Sivanaser; Pirjo Manninen
Journal:  Anesthesiol Res Pract       Date:  2010-03-31

6.  Assessing the effect of unilateral cerebral revascularisation on the vascular reactivity of the non-intervened hemisphere: a retrospective observational study.

Authors:  Kevin Sam; Julien Poublanc; Olivia Sobczyk; Jay S Han; Anne Battisti-Charbonney; Daniel M Mandell; Michael Tymianski; Adrian P Crawley; Joseph A Fisher; David J Mikulis
Journal:  BMJ Open       Date:  2015-02-11       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.